Banque Transatlantique Sa Seres Therapeutics, Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 8,139 shares of MCRB stock, worth $63,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,139Holding current value
$63,321% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MCRB
# of Institutions
65Shares Held
39.5MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$180 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$47.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$13.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$12.6 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$11.3 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $965M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...